Medis Technologies Schedules Year End Financial Results Conference Call


NEW YORK, March 24, 2009 (GLOBE NEWSWIRE) -- Medis Technologies Ltd. (Nasdaq:MDTL) ("Medis") today announced it is scheduled to issue its financial results for the fourth quarter and year ended December 31, 2008 prior to the opening of the stock market on Tuesday, March 31, 2009. Management will also conduct a conference call later that morning at 11:00 a.m. Eastern Time to review these results and discuss its business operations.

Interested parties may participate in the call by dialing 303-262-2053 approximately 10 minutes before the call is scheduled to begin and ask to be connected to the Medis conference call. The conference call will also be simultaneously broadcast over the Internet. A recorded replay of the conference call will be available until 12:00 a.m. Eastern Time on April 7, 2009. Listeners may dial 303-590-3000 and use the code 11128468 for the replay.

To listen to the live webcast, please go to www.medistechnologies.com and click on the conference call link. The conference call will be archived and accessible for approximately 30 days if you are unable to listen to the live call.

Schedule this webcast into MS-Outlook calendar (click open when prompted):

http://apps.shareholder.com/PNWOutlook/t.aspx?m=36032&k=97028E85

Medis Technologies' (Nasdaq:MDTL) (www.medistechnologies.com) is the creator of the first portable fuel cell generator. The company's first generation of products, Medis 24/7 Xtreme Portable Power Solution and the Medis Fuel Cell Power Emergency Kit are available at Amazon.com and the FuelCellStore.com. The portable fuel cells can provide up to 90 hours of "green" energy to power personal electronics (i.e. cell phones, MP3 players, flashlights, etc.) anywhere without the need for a wall socket or any external electricity source. Medis' indirect majority-owned subsidiary, Cell Kinetics Ltd., is engaged in the development and commercialization of the CKChip, a unique cell carrier platform intended for simultaneous fluoroscopic monitoring and analysis of thousands of individual living cells over time.

This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases you can identify those so-called "forward-looking statements" by words such as "may," "will," "should," "expects," "plans," "targets," "believes," "anticipates," "estimates," "predicts," "potential," or "continue" or the negative of those words and other comparable words. These forward-looking statements are subject to risks and uncertainties, product tests, commercialization risks, availability of financing and results of financing efforts that could cause actual results to differ materially from historical results or those anticipated. Further information regarding these and other risks is described from time to time in the Company's filings with the SEC. We assume no obligation to update or alter our forward-looking statements made in this release or in any periodic report filed by us under the Securities Exchange Act of 1934 or any other document, whether as a result of new information, future events or otherwise, except as otherwise required by applicable federal securities laws.

MDTL



            

Contact Data